No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Ironwood Pharmaceuticals Shares Surge on Competitor's Woes
Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Maintains Target Price $12
Here's Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)
Jefferies Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Cuts Target Price to $12
Ironwood Pharmaceuticals On Pace for Largest Percent Increase Since January 2014 -- Data Talk
Beam Therapeutics Picks Ironwood Pharmaceuticals Finance and Operations Chief as CFO